{"title":"Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus.","authors":"Tiantian Wei, Jing Shen, Lijun He, Wei Zhou, Hui Zhang","doi":"10.1080/17410541.2025.2478809","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The genetic variant rs13137 of miR-21 is associated with susceptibility in many diseases. However, the association with cognitive dysfunction (CD) in Chinese patients with systemic lupus erythematosus (SLE) remains unclear.</p><p><strong>Materials and methods: </strong>Two hundred and thirty SLE patients (Non-CD) and 230 SLE-related CD patients (CD) were recruited. MiR-21 level was calculated by qRT-PCR. The ROC curve was established to evaluate the diagnosibility. The independent risk factors were identified by multivariate logistic regression analysis.</p><p><strong>Results: </strong>The miR-21 in CD group was obviously increased. Compared to AA carriers, the miR-21 level in carriers of rs13137 AT/TT in CD group were significantly lower than those in Non-CD group. The AUC was 0.9023 with sensitivity of 78.70% and specificity of 90.87%. Comparison of genotype and allele frequencies indicated that SLE patients carrying rs13137 AT/TT genotype had low risk of CD. Multivariate logistic regression analysis showed that the rs13137 polymorphism, education years, and MoCA score were correlated with CD risk.</p><p><strong>Conclusion: </strong>The miR-21 rs13137 polymorphism was correlated with CD risk in the Chinese population. MiR-21 in rs13137 AT/TT carriers was significantly lower than that of AA genotype and the AT/TT genotype was correlated with low CD risk in SLE patients.</p>","PeriodicalId":94167,"journal":{"name":"Personalized medicine","volume":" ","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17410541.2025.2478809","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The genetic variant rs13137 of miR-21 is associated with susceptibility in many diseases. However, the association with cognitive dysfunction (CD) in Chinese patients with systemic lupus erythematosus (SLE) remains unclear.
Materials and methods: Two hundred and thirty SLE patients (Non-CD) and 230 SLE-related CD patients (CD) were recruited. MiR-21 level was calculated by qRT-PCR. The ROC curve was established to evaluate the diagnosibility. The independent risk factors were identified by multivariate logistic regression analysis.
Results: The miR-21 in CD group was obviously increased. Compared to AA carriers, the miR-21 level in carriers of rs13137 AT/TT in CD group were significantly lower than those in Non-CD group. The AUC was 0.9023 with sensitivity of 78.70% and specificity of 90.87%. Comparison of genotype and allele frequencies indicated that SLE patients carrying rs13137 AT/TT genotype had low risk of CD. Multivariate logistic regression analysis showed that the rs13137 polymorphism, education years, and MoCA score were correlated with CD risk.
Conclusion: The miR-21 rs13137 polymorphism was correlated with CD risk in the Chinese population. MiR-21 in rs13137 AT/TT carriers was significantly lower than that of AA genotype and the AT/TT genotype was correlated with low CD risk in SLE patients.